Reports
Life Science Analytics Market Share, Size, Trends, Industry Analysis Report, 2026 - 2034
REPORT DETAILS
REPORT DETAILS
ABOUT THIS REPORT
Life Science Analytics Market Summery
The global life science analytics market size was valued at USD 11.28 billion in 2025 and is expected to grow at a CAGR of 7.6% during the forecast period. The surging adoption of analytical solutions in clinical trials, the rising prevalence of chronic diseases, advances in technology, and the demand for improved data standardization are among the critical factors driving the growth of the life science analytics market.
Market Statistics
Key Takeaways
- North America dominated with the largest share of 43.3% in 2025. This is due to the presence of modern healthcare facilities in the region.
- Asia Pacific is projected to account for a significant share of 26.2% in 2025. The regional market is driven by increased investments and healthcare digitization.
- The sales & marketing support segment dominated with the largest share of 39.3% in 2025. The segment is driven by the growing use of technology by life science firms for marketing strategies.
- The predictive segment is projected to grow at a 15.1% CAGR during the projected period. Predictive analytics is widely used for accurately classifying patients and mitigating risks during early trial stages.
- The pharmaceutical segment dominated with a 51.8% revenue share in 2025, driven by high adoption of solutions for resource management.
Note: Figures and projections outlined in this report are the result of Polaris Market Research’s proprietary analytical processes, grounded in the latest available datasets and market observations.
Industry Dynamics
- The rising prevalence of chronic disease is fueling the growth of the life science analytics industry.
- The focus on reducing healthcare expenditure is contributing to the market expansion.
- Technological advancement is driving the growth.
- Data privacy and security concerns are limiting the adoption.
AI Impact on Life Science Analytics Market
- The application of artificial intelligence, including generative AI, in the life sciences analytics field is revolutionizing how organizations conduct clinical trials.
- AI in life science analytics is changing real-world evidence (RWE) analytics and accelerating drug development timelines.
- AI platforms facilitate real-time patient monitoring, flexible trial designs, and faster data analysis. This process will reduce the cost of clinical trials, increasing the overall success rates.
There is increasing adoption of analytics solutions in various healthcare applications, including clinical trials. These trials generally generate a massive amount of complex data, as so many activities are involved, and it is difficult to analyze all the generated data manually. This has led to the development of numerous data analytics solutions to support clinical trials.
Strategically, life science analytics benefits pharmaceutical, biotechnology, and medical device manufacturers by enabling them to better leverage complex clinical, genomic, and real-world data. Large, disparate data sets are transformed into actionable insights, enabling key decision-making initiatives across drug discovery, clinical trials, regulatory submittals, and launch. Consequently, life-science analytics has been pivotal to digital transformation in the life sciences industry.
Industry Dynamics
Growth Drivers
The growth of the global market is driven by factors such as the increasing adoption of technology in the biotechnology and pharmaceutical industries. Companies worldwide are adopting advanced technology such as analytical solutions. This rise in adoption is driven by the need for faster drug discovery and development and by the need to optimize clinical trials. Moreover, rising investment in pharmaceutical and biotechnology companies is another major life science analytics market drivers. This increase in investment is supporting companies in spending more on advanced analytics solutions and the skilled workforce needed to operate them, thereby driving growth.
The adoption of drug discovery analytics solutions helps companies evaluate and identify potential drug candidates, significantly reducing the time and costs for pharmaceutical companies and contract research organizations (CROs). At each stage of drug discovery and development, analyses evaluate the drug's safety and efficacy before proceeding to the next step. All these factors drive market growth for life science analytics.
Pharmaceutical companies have adopted digitization across every department, as it supports research and development and plays a critical role in improving the efficiency of manufacturing, marketing, and sales. The adoption of the technology in research & development and manufacturing processes has increased productivity and reduced errors.
Life science analytics industry players are pursuing various strategies, including new product launches such as Amazon HealthLake, which will help facilitate big data solutions and standardize patient information in healthcare. The rise in funding for major players is further driving growth. For example, Inference raised USD 60 million in Series B funding in December 2020 to help the company further develop its AI-powered software platform that has applications in clinical research, drug discovery, and operations.
Major Areas of Life Science Analytics Market
Clinical Analytics: Clinical analytics is concerned with analysis of patient and trial data to improve results and simplify clinical trials.
Pharma Analytics: Pharma analytics assists pharmaceutical firms in optimizing their process in terms of developing drugs, pricing, and strategies.
Predictive Analytics: Predictive analytics utilizes past data for predictions about future disease occurrences, treatment results, and success rates of trials.
Real-World Evidence (RWE): RWE is a type of data analysis that looks at real-world healthcare settings.
Big Data in Healthcare: Big data analytics is concerned with the analysis of large and complex healthcare-related datasets.
Segment Insights
Insight by Type
The descriptive segment dominated the industry and generated the highest revenue in 2025. This is due to the widespread use of descriptive solutions by life science players to better understand historical trends and real-time occurrences. Descriptive analytics is the foundation for advanced analytics because it helps the life science industry gain clarity into its data. Descriptive analytics in life sciences is used for traceability, performance, and benchmarking on both the clinical and commercial sides and, in turn, facilitates the development of advanced analytics.
The predictive type segment is projected to grow at the highest growth rate of CAGR 15.1% in the life science analytics industry during the projected period. Predictive analytics is widely used to accurately classify patients and mitigate risks during the early stages of trials in the life sciences analytics market. Moreover, this type of method is used in personalized medicine. The growth in demand for personalized medicine is further fueling this method, thereby boosting the growth of the life science analytics industry.
Insight by Application
The sales & marketing support segment holds the largest life science analytics market revenue share for life science analytics and generated the highest revenue share of 39.3% in 2025. The rapid growth of this segment in the life science analytics industry can be ascribed to the growing use of technology by life science firms to synchronize their sales and marketing strategies. Advanced sales and marketing analytics can help the life sciences industry refine its engagement strategy, manage market access, and optimize product performance. The need for post-marketing surveillance is driving up the use of technology in sales & marketing.
The research & development (R&D) segment of the life science analytics industry is projected to grow rapidly over the projected period due to rising product pipelines from medical device, biotechnology, and pharmaceutical companies.
Insight by End-use
The pharmaceutical segment dominated the life science analytics industry and generated the highest revenue share of 51.8% in 2025, driven by high adoption of solutions for resource management, increased drug utilization, and improved clinical trial efficacy. Additionally, rising investment in these companies is further driving demand for analytics solutions. These investments support companies in spending more on advanced solutions and the workforce needed to handle them.
The biotechnology segment is projected to grow rapidly over the projected period due to increased use of the technology in genome analysis and sequencing to reduce costs. Also, the availability of customized data analytics solutions is boosting the segment's growth.
Geographic Overview
North America dominated the market and generated the highest revenue share of 43.3% in 2025, owing to the availability of modern healthcare facilities, the upsurge in the elderly population, increasing cases of non-communicable diseases, the presence of prominent players, and the adoption of advanced analytical solutions in countries like the U.S. and Canada. The increasing number of clinical trials also drives market growth for life science analytics.
Which Factors Contribute to the Dominance of the U.S. Life Science Analytics Market?
The U.S. life science analytics market accounted for the largest share of revenue in North America in 2025. Massive growth in life science data, increased regulatory and FDA analytics compliance pressures, and growing demand for faster, more efficient R&D are prompting pharmaceutical, biotech, and medical device companies to invest in analytics solutions. In addition, AI-enabled insights, precision medicine initiatives, and cloud adoption propel the adoption of life science analytics solutions and services in the U.S. Further, the presence of major players in the country propels the industry expansion in the U.S.
The following table provides information on key stakeholders, their roles, and notable examples within the U.S.
| Stakeholders | Role | Key Players in the U.S. |
| Investors | Provide investment in technology advancement, R&D, and business expansion. | Venture Capital Firms: Andreessen Horowitz, Sequoia Capital Private Equity: Insight Partners |
| Governments & Regulatory Bodies | Develop regulations, policies, and financial instruments to support the life sciences industries. | U.S. Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH) |
| Academic Researchers & Organizations | Conduct primary research and team up with relevant industry players to apply the research results. | Harvard Medical School, Johns Hopkins University, Stanford University |
| Technology Providers | Develop and supply data analytics platforms, software, and infrastructure | Oracle Corporation (Oracle Analytics Intelligence for life sciences), SAS Institute Inc. (SAS Viya for life sciences), IBM Corporation (Watson Health) |
| Service Providers | Provide consultation, implementation, and support services to install life science analytics solutions. | Accenture Plc, Cognizant Technology Solutions Corporation, Wipro Limited |
| Contract Research Organizations (CROs) | Offer clinical trials, data analysis, and other outsourced research services. | IQVIA Holding Inc., Labcorp Drug Development, Parexel International |
| End Users | Use analytics solutions to boost research & development (R&D) and various commercialization processes. | Pharmaceutical Firms: Pfizer, Merck Biotechnology Companies: Amgen, Genentech Medical Device Manufacturers: Medtronic, Abbott Laboratories |
| Cloud & Infrastructure Providers | Supply the computing power and storage solutions required for large-scale data analytics. | Amazon Web Services (AWS), Google Cloud Platform, Microsoft Azure |
| Data Providers | Provide access to genomic data and real-world data necessary for analytics. | IQVIA, Tempus, Flatiron Health |
| Professional Associations & Standards Bodies | Create guidelines on the development of high-quality analytics solutions for interoperability. | HL7 International, Clinical Data Interchange Standards Consortium (CDISC), Pharmaceutical Research and Manufacturers of America (PhRMA) |
Asia Pacific accounted for a significant share of 26.2% in 2025, driven by increased investments and healthcare digitization. Growing healthcare spending, the adoption of advanced technologies, and the development of healthcare facilities and infrastructure will further drive the growth of the life science analytics industry. In addition, the presence of several CROs and pharmaceutical companies in countries such as India and China is expected to further drive the development of the life science analytics market in the region.
Competitive Insights
Players in the life science analytics industry are investing heavily in research and development to develop new analytical tools for various fields of life sciences. Companies are also entering into partnerships, collaborations, and acquisitions to gain a foothold in nascent markets.
Leading life science analytics market players differentiate themselves through AI-native analytics platforms, cloud-based solutions, and end-to-end management solutions for clinical trials. Such solutions allow life science companies to adapt and scale their analytics more effectively. Major players operating in the market include Cognizant, Accenture, IBM, SAS Institute, Inc., Oracle, Wipro Limited, Take Solutions Limited, and IQVIA.
List of Key Companies
Future of Life Science Analytics Market
The life science analytics market will experience rapid growth due to the adoption of AI-enabled analytical solutions. Personalized medicine and precision medicine will be some of the factors driving market demand for sophisticated data insights. Cloud-based technology and data integration capabilities are expected to enhance accessibility and efficiency within the industry.
Recent Developments
April 2026: Accenture invested in and partnered with Iridius to deploy compliance-first AI solutions. The solutions are focused on allowing life science companies to scale Agentic AI while ensuring regulatory traceability. (source: nasdaq.com)
January 2026: Illumina, Inc. introduced Illumina Connected Multiomics, a cloud-based research platform. This tool helps researchers analyze and view complex multiomic and multimodal biological data easily. It aims to simplify data integration, lower costs, and speed up progress in precision medicine. (Source: llumina.com)
January 2026: Ibex Medical Analytics, a leader in AI pathology, announced a major expansion of its biopharma unit. The company is extending its platform to support late-stage biomarker development, early research, biomarker discovery, and trial efficiency. This step aims to improve partnerships and impact across drug development. (Source: ibex-ai.com)
Life Science Analytics Market Segmentation
By Type Outlook (Revenue, USD Billion, 2021–2034)
- Reporting
- Descriptive
- Predictive
- Prescriptive
By Component Outlook (Revenue, USD Billion, 2021–2034)
- Software
- Services
By Application Outlook (Revenue, USD Billion, 2021–2034)
- Research & Development (R&D)
- Sales & Marketing Support
- Regulatory Compliance
- Supply Chain Analytics
- Pharmacovigilance
By Delivery Outlook (Revenue, USD Billion, 2021–2034)
- On-demand
- On-premise
By End-Use Outlook (Revenue, USD Billion, 2021–2034)
- Medical Devices
- Pharmaceutical
- Biotechnology
- Others
By Regional Outlook (Revenue, USD Billion, 2021–2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Life Science Analytics Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 11.28 billion |
| Market Size in 2026 | USD 12.23 billion |
| Revenue Forecast by 2034 | USD 23.65 billion |
| CAGR | 7.6% |
| Base Year | 2025 |
| Historical Data | 2021–2024 |
| Forecast Period | 2026–2034 |
| Quantitative Units | Revenue in USD billion, and CAGR from 2026 to 2034 |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regional Scope |
|
| Competitive Landscape | Life Science Analytics Industry Trend Analysis (2025) Company profiles/industry participants profiling include company overview, financial information, product/service benchmarking, and recent developments |
| Report Format | PDF + Excel |
| Customization | Report customization as per your requirements with respect to countries, regions, and segmentation. |
Seeking a more personalized report that meets your specific business needs? At Polaris Market Research, we’ll customize the research report for you. Our custom research will comprehensively cover the business data and information you need to make strategic decisions and stay ahead of the curve.
FAQ's
The global life science analytics market size is projected to reach USD 23.65 billion by 2034. It is expected to account for a CAGR of 7.6% between 2026 and 2034.
Life science analytics is applied in research and development, sales and marketing support, regulatory compliance, supply chain analytics, pharmacovigilance, and clinical trials.
The sales and marketing support segment has the largest market share of 39.3%. The segment is driven by the rise in the use of technology to synchronize marketing approaches and by post-marketing surveillance by life science companies.
North America accounts for the largest share of 43.3%. The regional market dominance is attributed to its modern healthcare facilities and strong regulatory frameworks.
AI increases the rate of drug discovery, the efficiency of clinical trials, the ability to analyze data from wearables and EMRs in real time, and the predictive power for applications of personalized medicine.
Download Sample Report of Life Science Analytics Market
Please fill out the form to request a customized copy of the research report.
